Reinfuse Chyme,
Help the Patient

The InsidesTM Company is the world’s leading provider of an award winning, therapeutic chyme reinfusion solution for the management of enterocutaneous fistula.

Latest News

… Read More of The Insides Company News & Press Release

Granted by the United States Food and Drug Administration (FDA)

Received the New Zealand Stock Exchange (NZX) Early Stage Companies Award in the 2019 TIN Report

People’s Choice for Best Project Award

Awarded the Innovative Research and Development Grant

Treating chyme as waste impedes the journey to recovery.

Chyme contains important nutrients and fluids that are lost when a patient with a loop ileostomy or enterocutaneous fistula empties their bag. This can result in complications such as:

Increased risk of Clostridium difficile
Hospital readmissions
Missed or reduced chemotherapy doses

Patients who lose large volumes of chyme may require parenteral nutrition to maintain hydration and replace electrolytes. However, this is expensive and introduces new risks, including line sepsis, vascular damage and liver diseases.

Chyme reinfusion is the new standard.

Using The InsidesTM Systemfi to return chyme via the distal stoma restores the patient’s natural bowel continuity.
This can improve:

Electrolyte balance
Liver function

Studies have shown that restoring bowel continuity in patients on parenteral nutrition allowed them to return to an oral diet.

"Chyme re-feeding reduces recovery time, while minimising harms attributed to a de-functioned colon"

Associate Professor Greg O'Grady